Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
22%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
2
18%
Ph phase_2
3
27%
Ph phase_1
3
27%
Ph early_phase_1
2
18%

Phase Distribution

5

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
2(20.0%)
Phase 1Safety & dosage
3(30.0%)
Phase 2Efficacy & side effects
3(30.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Terminated(2)

Detailed Status

Completed9
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
90.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (20.0%)
Phase 13 (30.0%)
Phase 23 (30.0%)
N/A2 (20.0%)

Trials by Status

withdrawn19%
terminated19%
completed982%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11